Esterified cholesterol accumulation induced by aggregated LDL uptake in human vascular smooth muscle cells is reduced by HMG-CoA reductase inhibitors

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 18, Issue 5, 1998, Pages 738-746

  Llorente Cortés, Vicenta ^a   Martínez González, José ^a,b   Badimon, Lina ^a,c  

^a CSIC   (Spain)

^b Inst Recerca Hosp S Creu Sant P   (Spain)

^c DEPT OF ENVIRONMENTAL CHEMISTRY   (Spain)

Author keywords

HMG CoA reductase inhibitors; LDL aggregation; Vascular smooth muscle cells

Indexed keywords

CHOLESTEROL; FARNESOL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LOW DENSITY LIPOPROTEIN; MEVALONIC ACID; RECOMBINANT PLATELET DERIVED GROWTH FACTOR; SIMVASTATIN;

ARTICLE; ATHEROSCLEROSIS; CELL PROLIFERATION; CONTROLLED STUDY; DRUG BINDING; DRUG MECHANISM; ENDOCYTOSIS; ENZYME INHIBITION; ESTERIFICATION; EXTRACELLULAR MATRIX; FLUORESCENCE MICROSCOPY; HUMAN; HUMAN CELL; PRIORITY JOURNAL; VASCULAR SMOOTH MUSCLE;

EID: 0031833783     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.ATV.18.5.738     Document Type: Article

References (19)

1. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and the acute coronary syndromes (part I). N Engl J Med. 1992;326:242-250.
2. Fuster V, Badimon L, Badimon JJ, Chesebro JH. The pathogenesis of coronary artery disease and acute coronary syndromes (part II). N Engl J Med. 1992;326:310-318.
3. Steinberg D, Parthasarathy S, Carew T, Khoo J, Witztum J. Beyond cholesterol: modifications of low-density lipoprotein that increase its atherogenicity. N Engl J Med. 1989;320:915-924.
4. Brown MS, Goldstein JL. Lipoprotein metabolism in the macrophage: implications for cholesterol deposition in atherosclerosis. Annu Rev Biochem. 1983;52:223-261.
5. Goldstein JL, Ho YK, Basu SK, Brown MS. Binding site on macrophages that mediates uptake and degradation of acetylated low density lipoprotein producing massive cholesterol deposition. Proc Natl Acad Sci USA. 1979;76:333-337.
6. Camejo G, Hurt-Camejo E, Rosengren B, Wiklund O, L-Pez F, Bondjers G. Modification of copper-catalyzed oxidation of low density lipoprotein by proteoglycans and glycosaminoglycans. J Lipid Res. 1991;32:1983-1991.
7. Vijayagopal P, Srinivasan SR, Radhakrishnamurthy B, Berenson GS. Factors regulating the metabolism of low density lipoprotein-proteoglycan complex in macrophages. Biochim Biophys Acta. 1990;1042:204-209.
8. Khoo JC, Miller E, McLoughlin P, Steinberg D. Enhanced macrophage uptake of low density lipoprotein after self-aggregation. Arteriosclerosis. 1988;8:348-358.
9. Khoo JC; Miller E, Pio F, Steinberg D, Witztum JM. Monoclonal antibodies against LDL further enhance macrophage uptake of LDL aggregates. Arterioscler Thromb. 1992;12:1258-1266.
10. Katsuda S, Boyd HC, Fligner C, Ross R, Gown AM. Human atherosclerosis, III: immunocytochemical analysis of the cell composition of lesions of young adults. Am J Pathol. 1992;140:907-914.
11. Wissler RW, Vesselinovitch D, Komatsu A. The contribution of studies of atherosclerotic lesions in young people to future research. Ann NY Acad Sci. 1990;598:418-434.
12. Tabas I, Yueqing L, Brocia RW, Wen Xu S, Swenson TL, Williams KJ. Lipoprotein lipase and sphingomyelinase synergistically enhance the association of atherogenic lipoproteins with smooth muscle cells and extracellular matrix. J Biol Chem. 1993;268:20419-20432.
13. Camejo G, Gunnar F, Rosengren B, Hurt-Camejo E, Bondjers G. Binding of low density lipoproteins by proteoglycans synthesized by proliferating and quiescent human arterial smooth muscle cells. J Biol Chem. 1993;268:14131-14137.
14. Nermine A, Ismail E, Zafar Alavi M, Moore S. Lipoprotein-proteoglycan complexes from injured rabbit aortas accelerate lipoprotein uptake by arterial smooth muscle cells. Atherosclerosis. 1993;105:79-87.
15. Tertov VV, Orekhov AN, Sobenin ZA, Gabbasov, Popov EG, Yaroslavov AA, Smirnov VN. Three types of naturally occurring modified lipoproteins induce intracellular lipid accumulation due to lipoprotein aggregation. Circ Res. 1992;71:218-228.
16. Tertov VV, Sobenin IA, Gabbasov ZA, Popov EG, Orekhov AN. Lipoprotein aggregation as an essential condition of intracellular lipid accumulation caused by modified low density lipoproteins. Biochem Biophys Res Commun. 1989;163:489-494.
17. Inaba T, Gotoda T, Shimano H, Shimada M, Harada K, Kozaki K, Watanabe Y, Hoh E, Motoyoshi K, Yazaki Y, Yamada N. Platelet-derived growth factor induces c-fms and scavenger receptor genes in vascular smooth muscle cells. J Biol Chem. 1992;267:13107-13112.
18. Li H, Freeman MW, Libby P. Regulation of smooth muscle cell scavenger receptor expression in vivo by atherogenic diets and in vitro by cytokines. J Clin Invest. 1995;95:122-133.
19. Goldstein JL, Brown MS. Regulation of mevalonate pathway. Nature. 1990;343:425-430.